Immunodietica is currently in the process of personalizing results for individuals based on their immunogenetic profile.
The company is in the process of formation to make available reports of individualized potential dietary interactions for consumers.
Our Team
Iosif Gershteyn CEO
Systems immunologist, serial entrepreneur involved in co-founding, principal investment, and advisory focused on early-stage biotechnology and medical device field.
Leonardo Ferreira CSO
Molecular immunologist. Human genome engineer. Deconstructing the immune system to achieve immune tolerance in type 1 diabetes and transplantation.